Cancer Lifeline Company Limited by Guarantee Statement of Financial Activities (including income and expenditure account) Year ended 31 March 2024 2024 Restricted funds Total funds Total funds 2023 Unrestricted funds Note Income and endowments Donations and legacies Charitable activities Other trading activities Other income 68.315 68,315 386,195 70,091 5,803 59,508 344,015 58,631 386,195 70,091 5.803 Total income 144.209 386,195 530,404 462,154 Expenditure Expenditure on raising funds: Costs of other trading activities Expenditure on charitable activities Total expenditure 114,691 52,079 114,691 458,053 47,016 422,465 10.11 405,974 166,770 405,974 572,744 469,481 Net expenditure (22.561) (19,779) (42,340) (7,327) Transfers between funds 162.785 (162.785) Net movement in funds 140.224 (182.564) (42,340) {7,327} Reconciliation of funds Total funds brought forward Total funds carried forward 370,286 190,544 560,830 568,157 510.510 7,980 518,490 560,830 The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. The notes on pages 26 to 37 fonn part of these financial statements. 23
Cancer Lifeline Company Limited by Guarantee Statement of Financial Position 31 March 2024 2024 2023 Note Fixed assets Tangible fixed assets 17 202,550 214,581 Current assets Debtors Cash at bank and in hand 18 5,443 372,207 900 363,585 377,650 364,485 Creditors: amounts falling due within one year Net current assets 20 61,710 18,236 315,940 346,249 Total assets less current liabilities 518,490 560,830 Net assets 518,490 560,830 Funds of the charity Restricted funds Unrestricted funds 7,980 510,510 190,544 370,286 Total charity funds 23 518,490 560,830 These financial statements were approved by the board of trustees and authorised for issue on 25 November 2024. and are signed on behalf of the board by: G Mathews Trustee B Montgomery Trustee The notes on pages 26 to 37 fonn part of these financial statements. 24
Cancer Lifeline Company Limited by Guarantee Statement of Cash Flows Year ended 31 March 2024 2024 2023 Note Cash flows from operating activities Nel expenditure (42,340) (7,327) Adjustments for.. Depreciation of tangible fixed assets Interest payable and similar charges Accrued expenses 12,031 1,848 8,520 14,087 2.008 Changes in." Trade and other debtors Trade and other creditors (4,543) 22,620 (900) 5,041 Cash generated from operations (1 ,864) 12,909 Interest paid (1 ,848) (3,712) (2,008) 10,901 Net cash (used in)Ifrom operating activities Cash flows from investing activities Purchase of tangible assets Nel cash used in investing activities (5,999) (5,999) Net (decrease)lincrease in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year (3,712) 350,390 4,902 345,488 19 346,678 350,390 The notes on pages 26 to 37 fonn part of these financial statements. 25
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements Year ended 31 March 2024 General inforniation The charity is a public benefit entity and a private company limited by guarantee, registered in Northern Ireland. The address of the registered office is 44 Alliance Avenue, Belfast. BT14 7PJ. Statement of compliance These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland., the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 1021 (Charities SORP {FRS 102)) and the Companies Act 2006. Accounting policies Basis of preparation The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure. The financial ststements are prepared in sterling. which is the functional currency of the entity. Going concern There are no material uncertainties about the charity's ability to continue. Judgements and key sources of estimation uncertainty The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experien and other factors. including expectations of future events that are believed to be reasonable under the circumstances. Fund accounting Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes. Designated funds are unrestricted funds eamiarked by the trustees for particular future project or commitment. Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-classes: restricted income fijnds or endowment fijnds. 26
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 Accounting policies (continuedj Incoming resources All incoming resources are included in the statement of financial activities when entitlement has passed to the charity- it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income- income from donations or grants is recognised when there is evidence of entitlement to the gift. receipt is probable and its amount can be measured reliably. legacy income is recognised when receipt is probable and entitlement is established. income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estimated resale value. Donated facilities and ServIS are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers. income from contracts for the supply of services is recognised with the delivery of the contracted servi. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent. in which case it may be regarded as restricted. Resources expended Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered. and is classified under headings of the statement of financial activities to which it relates- expenditure on raising funds includes the costs of all fundraising activities, events, non- charitable trading activities. and the sale of donated goods. expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for Ihe benefit of its beneficiaries, including those support costs and costs relating to the govemance of the charily apportioned to charitable activities. other expenditure includes all expenditure Ihat is neither related to raising funds for the charity nor part of its expenditure on charitable activities. All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable. justifiable and consistent basis. Tangible assets Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impaimient losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. 27
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 Accounting policies (continuedj Tangible assets (contlnued) An increase in the carying amount of an asset as a result of a revaluation, is recognised in other recognised gains and losses, unless it reverses a charge for impairment that has previously been recognised as expenditure within the statement of financial activities. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other recognised gains and losses. except to which it offsets any previous revaluation gain, in which case the loss is shown within other recognised gains and losses on the statement of financial activities. Depreciation Depreciation is calculated so as to write off the cost orvaluation of an asset, less its residual value, over the useful economic life of that asset as follows- Long leasehold property Motor vehicles Equipment 20/0 Straight line 25 % reducing balance 200/0 reducing balan Impaimient of fixed assets A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to eslimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expecled to benefit from the synergies of the combination, irrespective of whelher other assets or liabilities of the charity are assigned to those units. 28
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 Accounting policies (continuedj Financial instruments A financial asset or a financial liability is recognised only vthen the charity becomes a party to Ihe contractual provisions of the instrument. Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs. Current assets and cuThent liabilities are subsequenlly measured at the cash or other consideration expected to be paid or received and not discounted. Debt instruments are subsequently measured at amortised cost. Where investments in shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in income and expenditure. Al other such investments are subsequently measured at cost less impairment. Other financial instruments. including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measUd at fair value, with any changes recognised in the statement of finanual activities. with the exception of hedging instruments in a designated hedging relationship. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised under the appropriate heading in the statement of financial activities in which the initial gain was recognised. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impaimient. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised immedialely, lo the extent that the reversal does not result in a carrying amount of the financial asset that exceeds whal the carrying amounl would have been had the impairment not previously been recognised. Defined contribution plans Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. 29
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 Accounting policies (continuedj Defined contribution plans (contlnued) When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discounl is recognised as an expense in the period in which it arises. Limited by guarantee The charity is a public benefit entity and a private company limited by guarantee, registered in Northern Ireland and a registered charity in Northern Ireland. The address of the registered office is 187-189 Duncairn Gardens, Belfast, Antrim, BT15 2GF. Donations and legacies Unrestricted Total Funds Unrestricted Total Funds Funds 2024 Funds 2023 Donations Donations Collection boxes 63.948 4.367 63,948 4,367 54,962 4,546 54,962 4,546 68,315 68,315 59,508 59,508 Charitable activities Restricted Total Funds Funds 2024 Restricted Total Funds Funds 2023 DFC (Neighbourhood Renewal) The National Lottery Community Fund (People in Communities Programme) HSC {Public Health Agency) BHSCT (Carer's Support SeNices) BHSCT (Primary Care Talking Therapies) Belfast City Council (Revenue Grant) CFNI - The Comic Relief Empower Change Core Programme CFNI (through the Department of Health Cancer Charity Support Fund) The National Lottery Community Fund (through Dormant Accounts Nl) 77,948 77,948 83,319 83,319 50,254 93,520 11.124 50.254 93,520 11.124 60,915 74,099 10,488 60,915 74,099 10,488 3.266 49,981 3,266 49,981 4,556 18,500 4.556 18,500 12,320 12.320 73.565 73.565 66,667 66.667 26,537 26,537 13,151 13,151 386.195 386,195 344,015 344,015 30
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 Other trading activities Unrestricted Total Funds Unrestricted Total Funds Funds 2024 Funds 2023 Shop income 70,091 70,091 58,631 58,631 Other income Unrestricted Total Funds Unrestricted Total Funds Funds 2024 Funds 2023 Sundry income 5.803 5,803 Costs of other trading activities Unrestricted Funds Restricted Total Funds Funds 2024 Costs of other trading activities - Shop costs 114,691 114,691 Unrestricted Funds Restricted Total Funds Funds 2023 Costs of other trading activities - Shop costs 47,016 47,016 10. Expenditure on charitable activities by fund type Unrestricted Funds Restricted Total Funds Funds 2024 Charitable activity Support costs 36.448 15,631 354,030 51,944 390,478 67,575 52,079 405,974 458,053 Unrestricted Funds Restricted Total Funds Funds 2023 Charitable activity Support costs 117.029 48,608 256,828 165,637 256,828 117.029 305,436 422.465 31
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 11. Expenditure on charitable activities by activity type Activities undertaken directly Support costs Total funds 2024 Total fund 2023 Charitable activity Governance costs 390.478 54,235 13,340 444,713 13,340 418,865 3,600 390.478 67,575 458,053 422,465 12. Analysis of support costs Analysis of support costs Total 2024 Total 2023 Staff costs Premises Communications and IT General office Finan costs Governance costs 206,334 13,921 2,321 28,644 2,008 3,600 11,059 5,307 36,021 1,848 13.340 11,059 5,307 36,021 1,848 13,340 67,575 67,575 256,828 13. Net expenditure Net expenditure is stated after chargingl(crediting}- 2024 2023 Depreciation of tangible fixed assets 12,031 14,087 14. Auditors remuneration 2024 2023 Fees payable for the audit of the financial statements 4,260 15. Staff costs The total staff costs and employee benefrts for the reporting period are analysed as follows.. 2024 2023 Wages and salaries Social security costs Employer contributions to pension plans 235,757 18,814 20,424 208,355 12,647 19,125 274,995 240,127 32
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 15. staff costs (continuedl The average head count of employees during the year was 12 (2023: 13). No employee received employee benefits of more than £60,000 during the year {2023'. Nil). Key Management Personnel Key management personnel include all persons that have authority and responsibility for planning. directing and controlling the activities of the charity. The total compensation paid to key management personnel for services provided to the charity was £106,267. 16. Trustee remuneration and expenses No Trustee received emoluments during the year (2023'.Nil) The Trustees. received in total £2,172 (2023".£706) in reimbursement of expenses. The reimbursement is made for cost of travelling on Charity business in relation to their duties as Trustees. and also (as with other volunteers) the reimbursement of costs incurred during support visitations. 17. Tangible fixed assets Long leasehold property Motor vehicles Equipment Total Cost At 1 April 2023 and 31 March 2024 Depreciation At 1 April 2023 Charge for the year At 31 March 2024 293,983 11,000 129,380 434,363 103.997 5.880 6,875 1,031 108,910 5,120 219,782 12,031 109,877 7.906 114,030 231.813 Carrying amount At 31 March 2024 184,106 3,094 15,350 202,550 At 31 March 2023 189.986 4,125 20,470 214,581 33
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 18. Debtors 2024 2023 Trade debtors Prepayments and accrued income Other debtors 900 3,324 1,219 900 5,443 900 19. Cash and cash equivalents Cash and cash equivalents comprise the following: 2024 2023 Cash at bank and in hand Bank overdrafts 372,207 (25,529) 346,678 363,585 (13,195) 350,390 20. Creditors: amounts falling due within one year 2024 2023 Bank loans and overdrafts Trade creditors Accruals and deferred income Social security and other taxes 25,529 2,778 33,032 371 13,195 5,041 61,710 18,236 21. Deferred income 2024 2023 Amount deferred in year 24,512 22. Pensions and other post retirement benefits Defined contribution plans The amount recognised in income or expenditure as an expense in relation to defined contribution plans was £20.424 (2023: £19,125). 34
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 23. Analysis of charitable funds Unrestricted funds At 1 April 2023 At 31 March 2024 Income Expenditure Transfers General Funds General funds- propety fund Designated Fund 146.422 144.209 (166.770) (61,719) 62,142 161,996 62,508 161,996 286,372 223.864 370.286 144.209 (166.770) 162,785 510,510 At 1 April 2022 At 31 March 2023 Income Expenditure Transfers General Funds General funds- property fund Designated Fund 145.312 118,139 (117.0291 146,422 223.864 223,864 369.176 118.139 (117.029) 370,286 Restricted funds At 1 April 2023 At 31 March 2024 Income Expenditure Transfers Restricted Funds - operating fund Restricted - Property Fund DFC (Neighbourhood Renewal) National Lottery Community Fund (People in Communities) HSC {Public Health Agency) BHSCT (Carer's support service) 5.108 (5,108) 161,996 (161,996) 8,830 77,948 (86,778) 14.610 50.254 (64.864) 93.520 (93.520) 11.124 {11.124) 35
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 23. Analysis of charitable funds (continued) BHSCT (Primary care talking therapies) Belfast City Council (Revenue Grant) CFNI (through DOH Carer's grant) CFNI (through DOH Cancer Charity Support Fund) National Lottery Community Fund (Dormant Accounts) 3.266 (3.266) 49,981 (49,981) 6.898 (6.898) 66,667 {58,687) 7,980 26,537 (30,856) (405,974) (162,785) 4,319 190,544 386,195 7,980 At 1 April 2022 At 31 March 2023 Income Expenditure Transfers Restricted Funds - operating fund Restricted - Property Fund DFC (Neighbourhood Renewal) National Lottery Community Fund (People in Communities) HSC (Public Health Agency} BHSCT (Carer's support service) BHSCT (Primary care talking therapies) Belfast City Council (Revenue Grant) CFNI (through DOH Carer's grant) CFNI (through DOH Cancer Charity Support Fund) National Lottery Community Fund (Dormant Accounts) 36.985 344.015 (352.452) 28,548 161.996 161,996 198.981 344,015 (352.452) 190,544 36
Cancer Lifeline Company Limited by Guarantee Notes to the Financial Statements (continued) Year ended 31 March 2024 23. Analysis of charitable funds (continued) Transfers have taken place in the year in relation to the Property Fund as this fund is no longer restricted as the grant restriction has ended. Transfers have also taken place in the year to reclassify funds to unrestricted funds as the funds are available for any use. no restrictions have been placed on this. 24. Analysis of net assets between funds Unrestricted Funds Restricted Total Funds Funds 2024 Tangible fixed assets Current assets Creditors less than 1 year Net assets 202,550 345,158 (37,198) 510,510 202,550 377,650 (61,710) 518,490 32,492 (24,512) 7,980 Unrestricted Funds Restricted Total Funds Funds 2023 Tangible fixed assets Current assets Creditors less than 1 year Net assets 58,465 330,057 (18,236) 370,286 156,116 34,428 214,581 364,485 (18,236) 560,830 190,544 25. Analysis of changes in net debt At At 1 Apr 2023 Cash flows 31 Mar 2024 Cash at bank and in hand Bank overdrafts 363,585 (13,195) 350,390 8,622 {12,334) (3,712) 372,207 (25,529) 346,678 26. Contingencies A contingent liability exists to repay grants and Trust monies received should rtain conditions not be fulfilled by the charity. In the opinion of the Trustees, the terms of the Letters of Offers have been, or will be. complied with and no liability is expected. 27. Ethical standards In common with many other businesses of our size and nature we use our auditors to prepare and submit retums to the tax authorities and assist with the preparation of Ihe financial statements. 37